Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dimosthenis Antoniou"'
Publikováno v:
Multidisciplinary Respiratory Medicine
Multidisciplinary Respiratory Medicine, Vol 5, Iss 3, Pp 188-193 (2010)
Multidisciplinary Respiratory Medicine, Vol 5, Iss 3, Pp 188-193 (2010)
Lung resection is the mainstay of treatment in patients with early stage non-small cell lung cancer. However, lung cancer patients often suffer from comorbidities and the respiratory reserve should be carefully evaluated preoperatively in order to av
Autor:
Athanasios Athanasiadis, John Koutantos, George Papadopoulos, Dimitrios T. Trafalis, Alexandros Ardavanis, Dimosthenis Antoniou, P. Papakotoulas, Athanasios Anagnostopoulos, Dimitrios Pectasides, George P. Stathopoulos, Michael M Vaslamatzis
Publikováno v:
Anti-cancer drugs. 21(2)
Oral topotecan has been recently brought into clinical practice at a dose of 2.3 mg/m(2) for 5 days, every 3 weeks. Published data show quite high myelotoxicity. The aim of this trial was to define the daily dose and treatment duration, which permits
Autor:
Dimitris Karaindros, Athanasios Athanasiadis, Kostas Katis, Kyriaki Tsikritsaki, Pantelis Giamboudakis, S. K. Rigatos, J. Stathopoulos, Angeliki Rapti, Michalis Toumbis, John Koutantos, Dimosthenis Antoniou, George P. Stathopoulos, John Dimitroulis
Publikováno v:
Oncology reports. 20(4)
Cisplatin-paclitaxel and cisplatin-etoposide combination therapies were compared in limited and extensive disease in patients with small-cell lung cancer. The primary objectives were to determine median and overall survival, time to tumor progression
Autor:
Marinos Veslemes, George P. Stathopoulos, Kostas Kyprianou, Ourania Armenaki, Christos Skarleas, Dimosthenis Antoniou, Pantelis Giamboudakis, Georgia Kolitsi, Kostas Marosis, John Dimitroulis, Costas Katis, Chrysovalantis V. Papageorgiou
Publikováno v:
Scopus-Elsevier
The present study involves non-small cell lung (NSCLC) cancer patients with brain metastases, who were treated with radiation therapy, and our aim was to determine response rate and survival. A total of 167 patients were recruited, 155 (125 male, 30
Autor:
John, Stathopoulos, Dimosthenis, Antoniou, George P, Stathopoulos, Sotiris K, Rigatos, John, Dimitroulis, John, Koutandos, Pinelopi, Michalopoulou, Athanasios, Athanasiades, Marinos, Veslemes
Publikováno v:
Anticancer research. 25(5)
Our purpose was to evaluate the survival of patients with pleural and intraperitoneal malignant mesothelioma and, particularly, to estimate the efficacy of chemotherapy as well as radiotherapy and surgery. A review of the literature with respect to t
Autor:
Marinos, Veslemes, Dimosthenis, Antoniou, Niki, Georgatou, Pantelis, Giamboudakis, John, Dimitroulis, Kostas, Katis, George P, Stathopoulos
Publikováno v:
Anticancer research. 25(4)
The aim of this study was to evaluate the effectiveness of cisplatin- (CDDP) combined chemotherapy in non-cisplatin pretreated patients with non-small-cell lung cancer (NSCLC). The second cytotoxic drug administered was either etoposide or gemcitabin
Autor:
Panagiotis Misthos, Loukas Thanos, Dimosthenis Antoniou, Foteini Karakontaki, Chrysovalantis V. Papageorgiou, Nikos Koulouris, Georgios Kaltsakas, Iris Tsangaridou
Publikováno v:
Science Journal of Clinical Medicine. 2:134
Background-Aim: Prediction of postoperative FEV1 and diffusion capacity of the lung for carbon monoxide (DLCO) has a key role in the preoperative evaluation of lung resection candidates with impaired lung function. Additionally, dyspnea is a symptom